934 related articles for article (PubMed ID: 25563894)
1. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
4. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
Ginnebaugh KR; Ahmad A; Sarkar FH
Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
8. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
9. Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.
Nandy SB; Gangwani L; Nahleh Z; Subramani R; Arumugam A; de la Rosa JM; Lakshmanaswamy R
Future Oncol; 2015; 11(6):983-95. PubMed ID: 25760978
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
12. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
14. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.
Wang Z; Li Y; Ahmad A; Azmi AS; Kong D; Banerjee S; Sarkar FH
Drug Resist Updat; 2010; 13(4-5):109-18. PubMed ID: 20692200
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs and cancer stem cells: the sword and the shield.
Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs regulate tumor cell plasticity.
Liu B; Sun L; Song E
Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
Leal JA; Lleonart ME
Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
[TBL] [Abstract][Full Text] [Related]
19. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
20. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]